These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 8642551)
1. 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors. Rowley M; Broughton HB; Collins I; Baker R; Emms F; Marwood R; Patel S; Patel S; Ragan CI; Freedman SB; Leeson PD J Med Chem; 1996 May; 39(10):1943-5. PubMed ID: 8642551 [No Abstract] [Full Text] [Related]
2. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride. Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336 [TBL] [Abstract][Full Text] [Related]
3. 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. Kulagowski JJ; Broughton HB; Curtis NR; Mawer IM; Ridgill MP; Baker R; Emms F; Freedman SB; Marwood R; Patel S; Patel S; Ragan CI; Leeson PD J Med Chem; 1996 May; 39(10):1941-2. PubMed ID: 8642550 [No Abstract] [Full Text] [Related]
4. 4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptor. Rowley M; Collins I; Broughton HB; Davey WB; Baker R; Emms F; Marwood R; Patel S; Patel S; Ragan CI; Freedman SB; Ball R; Leeson PD J Med Chem; 1997 Jul; 40(15):2374-85. PubMed ID: 9240352 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship of the isoindolinyl benzisoxazolpiperidines as potent, selective, and orally active human dopamine D4 receptor antagonists. Hendrix JA; Shimshock SJ; Shutske GM; Tomer JD; Kapples KJ; Palermo MG; Corbett TJ; Vargas HM; Kafka S; Brooks KM; Laws-Ricker L; Lee DK; de Lannoy I; Bordeleau M; Rizkalla G; Owolabi J; Kamboj RK Chembiochem; 2002 Oct; 3(10):999-1009. PubMed ID: 12362366 [TBL] [Abstract][Full Text] [Related]
6. N-(1-Benzylpyrrolidin-3-yl)arylbenzamides as potent and selective human dopamine D4 antagonists. Egle I; Barriault N; Bordeleau M; Drage J; Dube L; Peragine J; Mazzocco L; Arora J; Jarvie K; Tehim A Bioorg Med Chem Lett; 2004 Oct; 14(19):4847-50. PubMed ID: 15341937 [TBL] [Abstract][Full Text] [Related]
7. (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist. TenBrink RE; Bergh CL; Duncan JN; Harris DW; Huff RM; Lahti RA; Lawson CF; Lutzke BS; Martin IJ; Rees SA; Schlachter SK; Sih JC; Smith MW J Med Chem; 1996 Jun; 39(13):2435-7. PubMed ID: 8691438 [No Abstract] [Full Text] [Related]
8. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. Patel S; Freedman S; Chapman KL; Emms F; Fletcher AE; Knowles M; Marwood R; Mcallister G; Myers J; Curtis N; Kulagowski JJ; Leeson PD; Ridgill M; Graham M; Matheson S; Rathbone D; Watt AP; Bristow LJ; Rupniak NM; Baskin E; Lynch JJ; Ragan CI J Pharmacol Exp Ther; 1997 Nov; 283(2):636-47. PubMed ID: 9353380 [TBL] [Abstract][Full Text] [Related]
9. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor. Tallman JF; Primus RJ; Brodbeck R; Cornfield L; Meade R; Woodruff K; Ross P; Thurkauf A; Gallager DW J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370 [TBL] [Abstract][Full Text] [Related]